Document is current
Any future updates will be listed below
-
Authors
Radwan, Rotana M.
Schuster, Anne L. R.
Hertz, Daniel L.
Lustberg, Maryam B.
Vachhani, Hetal R.
Hickey Zacholski, Erin
Sheppard, Vanessa B.
Bridges, John F. P.
Salgado, Teresa M.
-
Funding
Funding for this research was provided by:
Institutional Research Grant from the American Cancer Society and the VCU Massey Comprehensive Cancer Center (IRG-21-134-46, IRG-21-134-46)
NIH-NCI Cancer Center Support Grant (P30 CA016059, P30 CA016059)
Phi Kappa Phi Dissertation Fellowship Award
- License Information
-
More Information
Article History
Received: 31 October 2024
Accepted: 1 May 2025
First Online: 13 May 2025
Declarations
:
: The authors declare no competing interests relevant to the content of this article. Dr. Teresa M. Salgado received funding from Boehringer Ingelheim for diabetes-related research. Dr. John F.P. Bridges consults for Boehringer Ingelheim and Otsuka and Lundbeck, and holds an Innovation in Regulatory Science Award from the Burroughs Wellcome Fund, both of which are outside the scope of the submitted work.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Virginia Commonwealth University Institutional Review Board, and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
